Search tags
There were found 10 sibutramine
27/05/2013
Patients and physicians must sign a liability waiver, presented along with the prescription at the time of purchase
08/04/2013
The agency became mandatory reporting of adverse reactions related to the use of the drug, indicated for obesity
27/03/2013
Regulatory agency did a study on the drug and the report should be voted on next week by the board
02/01/2013
Authority must decide whether to maintain authorization for use of the drug in the country. In 2011, the agency decided to ban slimming
21/11/2012
Thereafter, the regulatory agency will decide whether to keep or not authorization for the use of slimming in the country
09/01/2012
Measure Moving in House for medicines worth amfepramone, femproporex, mazindol and sibutramine
27/12/2011
In the first phase campaign will run in nine of 43 radio capital, in February starts broadcasting on TV channels
23/12/2011
Authority warns that it's getting significant number of revenue without the B2 disclaimer and white without a prescription
14/10/2011
Board believes that it is the physician prescribing these products, and pharmaceutical handling enabled in pharmacies
10/10/2011
Anvisa decision will take effect in 60 days. Measure prohibits substances amfepramone, and mazindol femproporex
  • Twitter iSaúde
advertising
Informe Saúde printed version

Recommend the portal
Close [X]
  • You are recommending this story: http://www.isaude.net
  • Fill in the following form to send your recommendation to your friend:

RSS news from the portal  iSaúde.net
Get the newsletter of the portal  iSaúde.net
Recommend the portal iSaúde.net
News from  iSaúde.net in your blog or website.
Get news on the subject of your interest.
© 2000-2011 www.isaude.net Todos os direitos reservados.